Cited by 635Inflammatory Bowel DiseaseGenetic Associations and EpidemiologyOcular Diseases and Behçet’s Syndrome

New IBD genetics: common pathways with other diseases

Lees, C W, Barrett, J C, Parkes, M, Satsangi, J·2011·Gut

Abstract

Complex disease genetics has been revolutionised in recent years by the advent of genome-wide association (GWA) studies. The chronic inflammatory bowel diseases (IBDs), Crohn's disease and ulcerative colitis have seen notable successes culminating in the discovery of 99 published susceptibility loci/genes (71 Crohn's disease; 47 ulcerative colitis) to date. Approximately one-third of loci described confer susceptibility to both Crohn's disease and ulcerative colitis. Amongst these are multiple genes involved in IL23/Th17 signalling (IL23R, IL12B, JAK2, TYK2 and STAT3), IL10, IL1R2, REL, CARD9, NKX2.3, ICOSLG, PRDM1, SMAD3 and ORMDL3. The evolving genetic architecture of IBD has furthered our understanding of disease pathogenesis. For Crohn's disease, defective processing of intracellular bacteria has become a central theme, following gene discoveries in autophagy and innate immunity (associations with NOD2, IRGM, ATG16L1 are specific to Crohn's disease). Genetic evidence has also demonstrated the importance of barrier function to the development of ulcerative colitis (HNF4A, LAMB1, CDH1 and GNA12). However, when the data are analysed in more detail, deeper themes emerge including the shared susceptibility seen with other diseases. Many immune-mediated diseases overlap in this respect, paralleling the reported epidemiological evidence. However, in several cases the reported shared susceptibility appears at odds with the clinical picture. Examples include both type 1 and type 2 diabetes mellitus. In this review we will detail the presently available data on the genetic overlap between IBD and other diseases. The discussion will be informed by the epidemiological data in the published literature and the implications for pathogenesis and therapy will be outlined. This arena will move forwards very quickly in the next few years. Ultimately, we anticipate that these genetic insights will transform the landscape of common complex diseases such as IBD.

Integrity signals

Registry

Crossref · 10.1136/gut.2009.199679

Cites

177 of 177 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Lees, C. W., Barrett, J. C., Parkes, M., & Satsangi, J.
Affiliations
  • University of Edinburgh (GB)
  • Wellcome Sanger Institute (GB)
  • University of Cambridge (GB)
Corresponding author
Lees, C W
Venue
Gut
Publisher
BMJ
Published
2011-02-07
Volume
60
Issue
12
Pages
1739-1753
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
OpenAlex
W2105058392
Cited by
635
References
177
Citations by year
2026: 12 · 2025: 33 · 2024: 33 · 2023: 36 · 2022: 23 · 2021: 40 · 2020: 19 · 2019: 41 · 2018: 34 · 2017: 40 · 2016: 45 · 2015: 60 · 2014: 59 · 2013: 68 · 2012: 60
FWCI
7.39
Type
journal article
Language
en
Open access
closed
Locations
  • Gut (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
Keywords
inflammatory bowel disease, Crohn's disease, ulcerative colitis, shared genetic risk, disease overlap, IL-10, autophagy, innate immunity, NOD2, IRGM, ATG16L1, intestinal barrier function, type 1 diabetes, type 2 diabetes, immune-mediated diseases, pathogenesis
MeSH terms
Arthritis, Rheumatoid, Asthma, Colitis, Ulcerative, Crohn Disease, Dermatitis, Atopic, Diabetes Mellitus, Type 1, Humans, Lupus Erythematosus, Systemic, Mycobacterium Infections, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Genetic Predisposition to Disease, Genome-Wide Association Study, Genetic Loci

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review